| Patient | Mahalia Jackson |
|---|---|
| Date of birth | 1911-10-26 |
| Identifiers | MRN HR-ML035-SYN-TD; SSN (made up) 000-35-4692 |
| Document date | 1964-06-15 |
| Author | Beatrice Fontenot, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Hoarse voice and sore throat for three days, with a concert in four days. [S]
Ms. Jackson called on Monday and was seen the same day. A cold began five days ago, after a weekend of two concerts and a church service; for three days her voice has been hoarse and breaks on high notes, her throat is sore, and she has a mild dry cough. Her highest temperature at home was 37.5 °C. She has no breathlessness beyond her usual, no chest pain, no palpitations, and no shocks from her defibrillator. She takes prednisone 20 mg each morning, methotrexate 20 mg on Sundays with folic acid daily, atovaquone, metoprolol, alendronate and vitamin D, and has missed no doses. She has a concert on Friday and is worried about singing through it. She has had no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| Onset | Cold five days ago; hoarseness for three days |
| Voice | Hoarse; breaks on high notes; speaking voice tires by evening |
| Temperature | Highest 37.5 °C at home; 37.4 °C today |
| Context | On prednisone 20 mg daily and methotrexate 20 mg weekly; a concert in four days |
| Associated signs and symptoms | Sore throat and dry cough; no breathlessness beyond her usual, chest pain, palpitations, device shocks, or thoughts of self-harm |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever of 38.0 °C or more, chills or night sweats |
| Ears, nose, mouth, and throat | Positive | Hoarseness, sore throat and a runny nose; no mouth sores, white patches or ear pain |
| Respiratory | Positive | Mild dry cough; breathing no worse than her usual; no wheeze |
| Cardiovascular | Negative | No chest pain, palpitations or device shocks |
| Psychiatric | Negative | Worried about the concert; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning | 40 mg each morning | Oral route | 1964-03-09 to 1964-05-11 | completed | S |
| Prednisone 10 mg oral tablet, three tablets (30 mg) by mouth each morning for four weeks | 30 mg each morning for four weeks | Oral route | 1964-05-11 to 1964-06-08 | completed | S |
| Prednisone 20 mg oral tablet, one tablet (20 mg) by mouth each morning for four weeks | 20 mg each morning for four weeks | Oral route | 1964-06-08 to 1964-07-06 | completed | S |
| Methotrexate 2.5 mg oral tablet, six tablets (15 mg) by mouth once a week on Sundays | 15 mg once weekly | Oral route | 1964-03-09 to 1964-05-11 | completed | S |
| Methotrexate 2.5 mg oral tablet, eight tablets (20 mg) by mouth once a week on Sundays | 20 mg once weekly | Oral route | 1964-05-11 | active | S |
| Folic acid 1 mg oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 1964-03-09 | active | S |
| Atovaquone 750 mg/5 mL oral suspension, 1500 mg (10 mL) by mouth once daily with food | 1500 mg once daily with food | Oral route | 1964-03-09 to 1964-07-06 | completed | S |
| Alendronate 70 mg oral tablet, one tablet by mouth once weekly on rising, with a full glass of water, staying upright for 30 minutes | One tablet once weekly | Oral route | 1964-03-16 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 1964-03-09 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 1964-05-11 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1964-06-15 | Body height | 170 | cm | S |
| 1964-06-15 | Body weight | 93.4 | kg | S |
| 1964-06-15 | Body mass index (BMI) [Ratio] | 32.3 | kg/m2 | S |
| 1964-06-15 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1964-06-15 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1964-06-15 | Heart rate | 72 | /min | S |
| 1964-06-15 | Respiratory rate | 16 | /min | S |
| 1964-06-15 | Body temperature | 37.4 | Cel | S |
| 1964-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Vital signs recorded on 1964-06-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; hoarse, breathy voice; temperature 37.4 °C, pulse 72, blood pressure 134/84, oxygen saturation 97 percent on room air |
| Head, eyes, ears, nose, and throat | Mildly red throat without exudate; no thrush on the tongue, palate or throat; clear nasal discharge; ear drums normal |
| Neck | No tender or enlarged nodes; no stridor |
| Respiratory | Clear to auscultation; no crackles or wheeze |
| Cardiovascular | Regular rhythm; defibrillator pocket healed |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excluded | resolved | confirmed | R06.09 | S — Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation. |
| Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked for | resolved | confirmed | R00.2 | S — Synthetic finding; superseded when cardiac sarcoidosis was diagnosed. |
| Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raised | resolved | confirmed | E83.52 | S — Synthetic finding; resolved on treatment. |
| Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosis | active | confirmed | D86.2 | S — Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable). |
| Acute viral laryngitis: three days of hoarseness, a sore throat and a mild dry cough after a cold, without fever, on prednisone 20 mg and methotrexate; rapid influenza and COVID-19 tests negative; no thrush; resolved | active | confirmed | J04.0 | S — Synthetic acute infection; not a historical claim. |
| Cardiac sarcoidosis: first-degree atrioventricular block, ventricular ectopy (6 percent of beats) with nonsustained ventricular tachycardia, left ventricular ejection fraction 47 percent, patchy late gadolinium enhancement of the basal septum and inferolateral wall, and matching focal FDG uptake on PET; synthetic modern detail linked to the documented private account that sarcoidosis was in her heart | active | confirmed | D86.85 | S — Synthetic cardiac findings; the account that her doctors told her sarcoidosis was in her heart rests on her biographer (D, probable), and the interpretation of her later heart disease is R. |
| Long-term systemic glucocorticoid treatment for sarcoidosis, with bone, glucose, blood pressure, infection and eye risks to manage | active | confirmed | Z79.52 | S — Synthetic treatment status. |
| Dual-chamber implantable cardioverter-defibrillator, placed after sustained monomorphic ventricular tachycardia was induced at electrophysiology study; remote monitoring | active | confirmed | Z95.810 | S — Synthetic device status after the synthetic implant. |
Guideline basis: Baughman RP, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021;58(6):2004079 (PMID 34140301) (2021); Stachler RJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg 2018;158(1_suppl):S1-S42 (PMID 29494321) (2018)
Follow-up: Phone check in three days. Return if hoarseness lasts beyond four weeks or for fever, breathlessness or chest pain. Next planned review in August with the repeat FDG-PET. Next scheduled visit 1964-08-24: six months of treatment: repeat FDG-PET, steroid taper, and plans for touring. [S]